Neonatal Hospital Course and Outcomes of Live-born Infants with Trisomy 18 at Two Tertiary Care Centers in the United States

Abstract

Objectives Trisomy 18 is presumed to be a lethal chromosomal abnormality; medical management of infants with this aneuploidy is controversial. Our objective was to describe our approach and experience with trisomy 18 infants.

Study Design We reviewed the initial hospital course, management, and factors predicting discharge from the hospital from two large tertiary care neonatal intensive care units in the southern United States over 26 years.

Results Of the 29 infants with trisomy 18, 21 (72%) died in the hospital and 8 (28%) were discharged home. 19 (66%) infants received mechanical ventilation and 10 (34%) received inotropic medications. Eight infants had critical congenital heart defects; only one survived to discharge. Three infants underwent major surgeries; one cardiac surgery, one tracheoesophageal fistula repair, and one myelomeningocele repair. Median length of hospital stay was 14 days (range, 0–78) for all the infants and 31 days (range, 18–66) for those that were discharged home. Factors associated with discharge from the hospital were female sex, higher gestational age, and absence of critical congenital heart defects. Median survival time was 13 days and was significantly longer for females compared with males. Our 1-month and 1-year survival rates were 31% and 3.9% respectively.

Conclusion A significant proportion of infants with trisomy 18 were discharged home. These data are helpful in counseling parents of infants with trisomy 18.

Keywords

survival - congenital heart disease - neonatal intensive care unit discharge

• References

• 1 Carter PE, Pearn JH, Bell J, Martin N, Anderson NG. Survival in trisomy 18. Life tables for use in genetic counselling and clinical paediatrics. Clin Genet 1985; 27 (1) 59-61
• 2 Embleton ND, Wyllie JP, Wright MJ, Burn J, Hunter S. Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed 1996; 75 (1) F38-F41
• 3 Irving C, Richmond S, Wren C, Longster C, Embleton ND. Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years. J Matern Fetal Neonatal Med 2011; 24 (1) 137-141
• 4 Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 2003; 111 (4 Pt 1): 777-784
• 5 Brewer CM, Holloway SH, Stone DH, Carothers AD, FitzPatrick DR. Survival in trisomy 13 and trisomy 18 cases ascertained from population based registers. J Med Genet 2002; 39 (9) e54
• 6 Niedrist D, Riegel M, Achermann J, Schinzel A. Survival with trisomy 18—data from Switzerland. Am J Med Genet A 2006; 140 (9) 952-959
• 7 Vendola C, Canfield M, Daiger SP , et al. Survival of Texas infants born with trisomies 21, 18, and 13. Am J Med Genet A 2010; 152A (2) 360-366
• 8 Wu J, Springett A, Morris JK. Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011. Am J Med Genet A 2013; 161A (10) 2512-2518
• 9 Baty BJ, Jorde LB, Blackburn BL, Carey JC. Natural history of trisomy 18 and trisomy 13: II. Psychomotor development. Am J Med Genet 1994; 49 (2) 189-194
• 10 Bruns DA. Developmental status of 22 children with trisomy 18 and eight children with trisomy 13: implications and recommendations. Am J Med Genet A 2015; 167A (8) 1807-1815
• 11 Boghossian NS, Hansen NI, Bell EF , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Mortality and morbidity of VLBW infants with trisomy 13 or trisomy 18. Pediatrics 2014; 133 (2) 226-235
• 12 Kosho T, Nakamura T, Kawame H, Baba A, Tamura M, Fukushima Y. Neonatal management of trisomy 18: clinical details of 24 patients receiving intensive treatment. Am J Med Genet A 2006; 140 (9) 937-944
• 13 Lin HY, Lin SP, Chen YJ , et al. Clinical characteristics and survival of trisomy 18 in a medical center in Taipei, 1988-2004. Am J Med Genet A 2006; 140 (9) 945-951
• 14 Subramaniam A, Jacobs AP, Tang Y , et al. Trisomy 18: a single-center evaluation of management trends and experience with aggressive obstetric or neonatal intervention. Am J Med Genet A 2016; 170 (4) 838-846
• 15 Kaneko Y, Kobayashi J, Achiwa I , et al. Cardiac surgery in patients with trisomy 18. Pediatr Cardiol 2009; 30 (6) 729-734
• 16 Muneuchi J, Yamamoto J, Takahashi Y , et al. Outcomes of cardiac surgery in trisomy 18 patients. Cardiol Young 2011; 21 (2) 209-215
• 17 Nakai Y, Asano M, Nomura N, Matsumae H, Mishima A. Effectiveness of cardiac surgery in patients with trisomy 18: a single-institutional experience. Cardiol Young 2016; 28: 1-6
• 18 Bos AP, Broers CJ, Hazebroek FW , et al. Avoidance of emergency surgery in newborn infants with trisomy 18. Lancet 1992; 339 (8798) 913-915
• 19 Paris JJ, Weiss AH, Soifer S. Ethical issues in the use of life-prolonging interventions for an infant with trisomy 18. J Perinatol 1992; 12 (4) 366-368
• 20 Carey JC. Perspectives on the care and management of infants with trisomy 18 and trisomy 13: striving for balance. Curr Opin Pediatr 2012; 24 (6) 672-678
• 21 Janvier A, Farlow B, Wilfond BS. The experience of families with children with trisomy 13 and 18 in social networks. Pediatrics 2012; 130 (2) 293-298
• 22 McGraw MP, Perlman JM. Attitudes of neonatologists toward delivery room management of confirmed trisomy 18: potential factors influencing a changing dynamic. Pediatrics 2008; 121 (6) 1106-1110
• 23 Blank RH. End-of-life decision making across cultures. J Law Med Ethics 2011; 39 (2) 201-214
• 24 Guon J, Wilfond BS, Farlow B, Brazg T, Janvier A. Our children are not a diagnosis: the experience of parents who continue their pregnancy after a prenatal diagnosis of trisomy 13 or 18. Am J Med Genet A 2014; 164A (2) 308-318